AnaptysBio, Inc. ANAB
NASDAQ · United States · Health Technology
$48.63-1.63 (-3.24%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-09-21 | 4.93 | 0.14 | +3,421.4% | $27.49M | 0.0% | -2.3%$55.20→$53.92 |
| Q1 2026 | 2026-05-12 | -1.84 | -0.32 | -475.0% | — | — | -7.7%$67.92→$62.69 |
| Q4 2025 | 2026-03-03 | 1.58 | 0.93 | +69.9% | — | — | +10.3%$36.61→$40.37 |
| Q3 2025 | 2025-11-04 | 0.52 | -1.06 | +149.1% | — | — | -0.1%$24.03→$24.00 |
| Q1 2025 | 2025-05-05 | -1.28 | -1.46 | +12.3% | — | — | — |
| Q4 2024 | 2025-02-27 | -0.72 | -1.70 | +57.6% | — | — | — |
| Q3 2024 | 2024-11-05 | -1.14 | -1.61 | +29.2% | — | — | — |
| Q2 2024 | 2024-08-05 | -1.71 | -0.93 | -83.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.